Autoantibodies from a patient with systemic lupus erythematosus, which recognize U1 and U2 small nuclear ribonucleoprotein particles (snRNPs), were used to map B-cell autoepitopes on the U1 snRNP-specific A protein. This protein contains two regions that are highly similar to regions in the U2 snRNP-specific B" protein. A site termed epitope 2 maps in one such region and was found to react with antibodies crossreactive between A and B". A second site, epitope 1, is situated in a proline-rich region that shows no homology with B". This epitope can bind three different autoantibodies with distinct
The U small nuclear RNA (snRNA)-containing small nuclear ribonucleoprotein particles (snRNPs) play key roles in the maturation process of pre-mRNAs (1) . The five most abundant nucleoplasmic U snRNAs are organized in four different snRNPs: U1, U2, U4/U6, and U5 (U1-U6) snRNPs. All four snRNP particles contain the so-called Sm core complex, consisting of proteins called B', B, D, D', E, F, and G. In addition to this core, U1 snRNPs contain three specific polypeptides, A, C, and the 70-kDa peptide, whereas U2 snRNPs are characterized by the presence of two unique proteins, A' and B" (2) . Recently another snRNP-associated polypeptide designated "N" was identified, which is expressed predominantly in brain (3) .
Autoantibodies against snRNPs often spontaneously occur in sera from patients with connective tissue diseases (reviewed in ref. 4) . The primary event that triggers autoantibody production is not known, but there is increasing evidence that this reaction might be antigen-driven (4, 5) .
Recently we described the molecular cloning of a cDNA containing the entire coding sequence for the U1 snRNPspecific A protein (6) . This protein presents an excellent model for studies of autoimmune phenomena in systemic lupus erythematosus (SLE) and related diseases because at least three different autoantibody responses against this protein have been described. Anti-A antibodies occur in (i) anti-(Ul)RNP sera commonly obtained from patients with mixed connective tissue disease (7, 8) ; (ii) in anti-Sm [anti-(U1-U6)RNP] sera (6, 9) , almost exclusively obtained from patients with SLE; and (iii) in anti-(Ul,U2)RNP sera (10) , which do not show a strong correlation with disease. Information on the exact structure of B-cell epitopes recognized by antibodies in these three classes of sera might provide insight into the nature of the autoimmune abnormalities.
We describe here three different populations of autoantibodies that cross-react with proline-rich regions in the snRNP proteins A, B'/B, N, and C and with an as-yet-unidentified 50-kDa protein. Our results support the hypothesis that autoantibody production is antigen-driven and show that the immune response against individual snRNP proteins can differ from patient to patient.
MATERIALS AND METHODS
Construction and Screening of a AHA-4 DNase Fragment Library. One microgram of the EcoRI cDNA insert of the previously described clone AHA-4 (6) was digested with 2 ng of DNase I in 10 Al of 20 mM Tris (pH 7.4) in the presence of 1.5 mM Mn2+ at room temperature (11) . Aliquots (3 ul) were taken at 3, 4, and 5 min and pooled. DNA was made blunt-ended with T4 polymerase, dialyzed against H20, and ligated to phosphorylated EcoRI linkers (12) . The material was digested with EcoRI and fractionated on 8% acrylamide gels to remove unligated linkers. Fragments of 50-250 base pairs (bp) were eluted, and 200 ng of the DNA was ligated into Agtll arms and packaged into phage heads (Promega Biotec). Recombinant phages were amplified in Escherichia coli Y1090 (13) and plated at a density of 3 x 104 per 150-cm2 plate. Screening with the previously characterized (10) human autoimmune serum V26 was performed as described (14) .
Characterization of Autoimmune Sera. The autoimmune sera used in this study were analyzed by immunoblotting with nuclear extract from HeLa cells (15) , by counter immunoelectrophoresis (16) , and by immunoprecipitation from radiolabeled cell extracts (10) . Classification of sera was done as follows. Sera that precipitated exclusively U1 snRNP were in all cases found to recognize one or more of the U1 snRNP-specific proteins (A, C, or the 70-kDa protein) and were classified as anti-(Ul)RNP. All sera containing antibodies reactive with U1 and U2 snRNPs were found to recognize B" and A and sometimes also one of the U1 snRNP-specific 70-kDa or C proteins. These sera were classified as anti-(Ul,U2)RNP. Sera precipitating U1, U2, U5, and U4/U6 were classified as anti-Sm. Sometimes sera contained both anti-Sm and anti-(Ul)RNP antibodies. This was the case when disproportionate amounts of U1 snRNPs, as compared with U2 snRNPs, were precipitated. These sera are referred to as anti-RNP/Sm.
Abbreviations: snRNA, small nuclear RNA; snRNP, small nuclear ribonucleoprotein particle.
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Analysis of Recombinant Antigen and Afflnity Purification of Antibody. Expression of recombinant antigen was induced with isopropyl 8-D-thiogalactoside as described (13, 14) . Bacterial lysates (14) were fractionated on preparative 10% acrylamide gels and blotted onto nitrocellulose. Strips containing the recombinant 83-galactosidase fusion protein were cut out and used for affinity purification of autoantibodies as described by Smith and Fisher (17) . As a control, antibodies were eluted from blot strips containing 8-galactosidase. These strips were cut from blots containing a bacterial lysate from induced E. coli strain BNN 97 (13) . ELISA with Synthetic Peptides. Synthetic peptides were designed from the predicted amino acid sequences ofproteins A (6) and N (18) and obtained from the European Veterinary Laboratory, Biotech Division (Amsterdam) (A peptide) and from the Protein and Nucleic Acid Chemistry Facility (Yale University) (N peptides). Nunc 96-well microtiter plates were coated overnight at 4°C with these peptides at 0.5 ,ug per well in coating buffer (15 mM Na2CO3/35 mM NaHCO3, pH 9.6). Plates were washed five times with PBST (20 mM sodium phosphate, pH 7.3/130 mM NaCI/0.05% Tween 20) , and the remaining binding sites were blocked with 1% bovine serum albumin in PBST for 2 hr at room temperature. Affinitypurified antibodies eluted from 200 ,g of nitrocellulosebound recombinant antigen (see above) were recovered in a volume of 2 ml. Fifty microliter was added to each well and incubated for 2 hr at room temperature. Bound antibodies were washed with PBST and detected as described (19) .
RESULTS
Construction and Screening of an Epitope Library. In a previous report, we described the isolation and characterization of a cDNA clone, AHA-4, that encodes the human U1 snRNP-specific A protein (6) . This protein expresses multiple epitopes that are recognized by autoantibodies in sera from patients with certain connective tissue diseases (6, 19) . Epitope-containing sequences within the A protein could be precisely mapped by screening a sublibrary made in Agtll that contained 50-to 250-bp-long random DNA fragments from the 1.2-kilobase EcoRI insert ofclone AHA-4. Screening was performed with the human anti-(Ul,U2)RNP serum V26 (10) .
From a total of 2 x i0s individual phages, 18 were found that encoded fusion proteins reactive with antibodies in the V26 serum. Four appeared to contain more than one insert and were excluded from further study. The inserts from the remaining 14 were subcloned into phage M13, and their sequences were determined (20) . All clones were found to be in the correct reading frames to allow expression of fusion proteins containing ,3-galactosidase and parts of A.
Definition of Two Autoepitopes on the A Protein. All 14 clones from which immunoreactive fusion proteins could be derived were found to encode amino acid sequences situated in the C-terminal half of the coding region of the A protein.
When the amino acid sequence of an epitope is defined as the minimum predicted sequence shared by clones with similar immunologically reactive properties, two separate epitopes can be identified (Fig. 1) . Epitope 1 covers amino acids 165-185 and is situated in a sequence unique to the A protein (nonshaded area in Fig. 1 ), whereas epitope 2 (amino acids 232-256) lies in a region of the A protein that shows extensive homology with a region of the B" protein (shaded area in Fig.  1 ; refs. 6 and 14) .
Evidence that these epitopes are distinct entities was obtained from experiments that show that different antibody populations bind to epitopes 1 and 2. A Agtll clone encoding amino acids 165-190 of the A protein (hereafter termed clone A165-190) was induced, and the expressed f-galactosidase fusion protein was used to affinity-purify autoantibodies from serum V26. The affinity-purified antibodies reacted exclusively with the A protein when they were used to probe a blot containing total nuclear proteins derived from HeLa cells (Fig. 2, lane epil) . Antibodies affinity-purified from serum V26 by using epitope 2 (as contained in a clone termed A232-268), on the other hand, recognized a cross-reactive epitope on A and B" (Fig. 2, lane epi2) .
As a next step we wished to establish whether the recognition of epitope 2 was a specific feature of antibodies in serum V26 or a more general phenomenon. (10, 14) and are considered to be degradation products of B". 70K, U1 sn-RNA-associated 70-kDa protein. (U1)RNP (n = 9), anti-Sm (n = 9), and anti-(Ul,U2)RNP sera (n = 8). None of the anti-(Ul)RNP or anti-Sm sera recognized epitope 2 as defined by their lack of reactivity with fusion proteins encoded by clones A232-268 or A210-256. Meanwhile, four of eight anti-(U1,U2)RNP sera recognized fusion proteins expressed by both clones. Therefore, we conclude that epitope 2 is exclusively recognized by A and B" crossreactive antibodies in some anti-(U1,U2)RNP sera.
Epitope 1-Like Sequences Are Present in Other snRNP Proteins. Epitope 1 was subjected to a more detailed study. The same panel of anti-snRNP sera used previously was tested on immunoblots containing fusion proteins encoded by clones A165-190 and A158-185. None of the nine anti-(U1)RNP sera reacted with either of the clones, whereas six of nine anti-Sm sera recognized epitope 1. Four of eight anti-(U1,U2)RNP sera also reacted with epitope 1, two of which (including serum V26) were already known to react with epitope 2 as well (see above). So epitope 1 bound antibodies from some anti-Sm sera as well as from some anti-(Ul,U2)RNP sera.
When the epitope 1-binding antibodies from an anti-Sm serum called K22 were eluted from blots containing fusion proteins encoded by either A158-185 or A165-190 and used to reprobe blots with nuclear proteins from HeLa cells, these antibodies behaved differently from the anti-epitope 1 antibodies in serum V26. Instead of a reaction with the A protein (as was the case for V26-derived antibodies, Fig. 2 FIG. 5. ELISA with epitope 1-affinity-purified antibodies from anti-Sm serum K22 or anti-(U1,U2)RNP serum V26. Microtiter plates were coated with four different peptides. Peptide A is the 21-amino acid sequence designated epitope 1 in Fig. 1 . Peptides N1 and N2 are designed from a region on the N protein that has the highest similarity with epitope 1 (see Fig. 4 ). Peptide N3 is a control containing amino acids 49-65 from the N peptide (18) .
with proteins B'/B and an as-yet-unidentified protein with a molecular mass of 50 kDa (marked as 50K in Fig. 3A) . Almost no reaction with the A protein was detectable, suggesting a much higher affinity of these antibodies for the B'/B and 50-kDa proteins. Incubation of the same antibodies with blots containing snRNP proteins showed that the 50-kDa protein was not an integral part of snRNPs, whereas A and B'/B were recognized in approximately the same ratio as observed in total nuclear protein blots (Fig. 3A) . That these antibodies still recognized Sm is shown in Fig. 3B . Epitope 1 affinitypurified antibodies from serum K22 precipitated U1-U6 snRNPs from a radiolabeled HeLa cell extract. It is interesting to note that serum K22 also recognized additional epitopes on the A protein. When antibodies from K22 were bound to and then eluted from full-length recombinant A protein, in addition to recovering anti-epitope 1 antibodies, antibodies strongly reactive with the A protein were recovered as well (Fig. 3A, lane tot.A) .
The simplest explanation for the observed cross-reactivities is that the A, B'/B, and 50-kDa proteins have common epitopes. Therefore, epitope 1 was compared with the primary sequence of B'/B and another recently described B-like, 24,614-Da snRNP protein called "N," which is found predominantly in brain (3, 18) . In the carboxyl terminus of N, six versions of epitope 1 could be detected with a similarity ranging from 47% to 63% (Fig. 4) . Since the primary sequence of N is highly homologous to B'/B (J. Hardin, Yale University, personal communication), several epitope 1 versions are also present in the B proteins, meaning that this is the region that most likely binds the epitope 1-purified antibodies. Because proteins N and B'/B can be difficult to resolve on immunoblots from sodium dodecyl sulfate/polyacrylamide gels (3, 18), a different assay was used to substantiate the hypothesis that epitope 1-eluted antibodies react with protein N. We developed an ELISA with synthetic epitope 1 (peptide A) and three peptides designed from N (sequences shown in Fig. 4 ). Fig. 5 the anti-Sm serum K22 reacted strongly with peptide N1 (amino acids 216-238 of N) and to a lesser extent with peptide A (epitope 1). No reaction was observed with peptide N2 (a fragment of N1; amino acids 223-232) or with peptide N3 (amino acids 49-65 of N). By comparison, the epitope 1-specific antibodies from V26 (the same as used to probe the immunoblots shown in Fig. 2) were tested, and these did not react with any of the N peptides but did bind the A peptide (Fig. 5 ).
Antibodies to Epitope 1 also React with the C Protein.
Affinity purification experiments performed as described above with two additional anti-snRNP sera revealed that a third antibody population can occur. This population was found in both a serum containing anti-RNP/Sm (as represented by serum H13) and in one containing anti-(Ul,U2)-RNP antibodies (serum C03). Antibodies eluted from epitope 1 originating from either of these sera reacted with snRNP proteins B'/B and C and only weakly with A (Fig. 6, lane  epil) . To prove that the reaction was directed against authentic C protein, the eluted antibodies were used to probe blots containing immunopurified snRNP proteins and still were found to identify the C protein (W.J.H., unpublished data). Vice versa, antibodies eluted from cloned C protein (23) cross-reacted with the A and B'/B proteins (Fig. 6 , lane C-F.P.). Epitope 1 antibodies from both H13 and C03 also recognized N, as shown by their reactivity with peptide N1 in the above-described ELISA (Fig. 7) . A possible explanation for the cross-reactivity between proteins A and C is presented in Fig. 8 . Five versions of epitope 1, ranging from 39% to 67% identity, are contained in the carboxyl-terminal half of the C protein. DISCUSSION We previously identified a cDNA clone, called AHA-4, encoding the human U1 snRNP-associated A protein (6) . In this study we have used a DNase I sublibrary (a so-called epitope library; ref. 11) of the original cDNA clone to define two regions on the A protein that interact with autoantibodies from anti-(U1,U2)RNP and anti-Sm sera.
The region identified in this study as epitope 2 on protein A differs only in two amino acids from a corresponding region (amino acids in protein B" (6, 14) . Therefore, it was not surprising that this site was recognized by A and B" cross-reactive antibodies. However, this site cannot be the only cross-reactive epitope because four other anti-(U1, U2)RNP sera did not react with epitope 2, whereas they recognized full-length B" when expressed as j3-galactosidase fusion protein (W.J.H., unpublished data). Such a polyclonal antibody response was also found in the case of proteins A and C (see below).
Epitope 1 was particularly interesting because it was recognized by three different populations of autoantibodies ( Table 1) . The first population was found in the anti-(U1,U2)RNP serum V26 and reacted with a sequence within epitope 1 that is not present in any of the other snRNP proteins. The second antibody specificity was present in the anti-Sm serum K22 and also recognized a sequence within epitope 1 but reacted more strongly with proteins B'/B and an unidentified 50-kDa protein as well as a peptide representing part of N than they did with A. This 50-kDa protein is not the La protein, as the reactive antibodies did not recognize cloned or natural La protein on immunoblots (W.J.H., unpublished data). Also it is probably not a snRNP protein because it is lost upon purification of snRNPs from cell extracts with anti-m3G antibodies (Fig. 3A) . A third antibody specificity that could be affinity-purified from epitope 1 reacted with proteins A, B'/B, and C and with a peptide representing part of N.
It was surprising that the epitope 1 affinity-purified antibodies derived from sera K22, C03, and H13 reacted only weakly with the A protein, whereas they reacted strongly with proteins B'/B (Figs. 3A and 6 ). This could mean that the epitope 1 (Figs. 5 and 7) . We have further shown that the immune reaction against snRNP proteins B", A, and C is polyclonal. When the antibody populations purified by using full-length A and C proteins (Fig. 3A, 
